申请人:Negoro Nobuyuki
公开号:US20120172351A1
公开(公告)日:2012-07-05
A compound represented by the formula (I): wherein each symbol is as defined in the specification, and a salt thereof have a GPR40 receptor activation action and is useful as an insulin secretagogue or a prophylactic or therapeutic drug for diabetes and the like.
化合物的化学式为(I),其中每个符号如规范所定义,其盐具有GPR40受体激活作用,并可用作胰岛素分泌剂或糖尿病等的预防或治疗药物。